Amgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both ...

Shares of Amgen Inc. AMGN rallied 1.03% to $280.35 Wednesday, on what proved to be an all-around mixed trading session for ...

In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.

JLL Capital Markets secured $182M in construction financing & equity for Latigo Group's 333-unit Hillcrest Apartments in ...

Talented female scientists are being pushed out of cancer research due to gender discrimination, ageism and an absence of ...

AI partners Microsoft and OpenAI’s cooling relationship cools further with Amgen’s switch from Copilot to ChatGPT.

Despite investing tens of billions of dollars into OpenAI, Microsoft is still, apparently, competing with its business ...

Artificial intelligence chatbots are fast becoming staples of modern office life, but it’s clear that not all tools are ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

RALEIGH, N.C. (June 25, 2025) – Apprenticeships took center stage as U.S. Education Secretary Linda McMahon visited Wake Tech ...